Importance of urine drug testing in the treatment of chronic noncancer pain: Implications of recent medicare policy changes in Kentucky

Pain Physician

Volumn 13, Issue 2, 2010, Pages 167-186

  Gilbert, John W ^a   Wheeler, G R ^a   Mick, G E ^a   Storey, B B ^a   Herder, S L ^a   Richardson, G B ^a   Watts, E ^a   Gyarteng Dakwa, K ^a   Marino, B S ^a   Kenney III, C M ^a   Siddiqi, M ^a   Broughton, P G ^a  

^a Spine and Brain Neurosurgical Center   (United States)

Author keywords

Chronic noncancer pain; Drug abuse; Medicaid; Medicare; Opioids; Urine drug testing

Indexed keywords

AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BUPRENORPHINE; COCAINE; METHADONE; NALOXONE; NARCOTIC ANALGESIC AGENT; OPIATE;

ADDICTION; ALCOHOL CONSUMPTION; ANALGESIA; CHRONIC PAIN; DECISION MAKING; DRUG ABUSE; DRUG MISUSE; DRUG SCREENING; DRUG USE; GOVERNMENT; HUMAN; INDUSTRY; MEDICAL ETHICS; MEDICARE; OPIATE ADDICTION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHOSOCIAL CARE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIOECONOMICS; SUBSTANCE ABUSE; UNITED STATES; URINALYSIS; WORKPLACE;

HISTORY, 20TH CENTURY; HUMANS; KENTUCKY; LEGISLATION, DRUG; MEDICARE; OPIOID-RELATED DISORDERS; PAIN, INTRACTABLE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS; SUBSTANCE ABUSE DETECTION; UNITED STATES; URINALYSIS;

EID: 77950673017     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (208)

1. Bedard M. Fact sheet on chronic nonmalignant pain 1997. www.druglibrary.org/schaffer/asap/factsheet.html. Accessed April 19, 2009.
2. Manchikanti L. Singh V, Datta S, Cohen SP, Hirsch JA. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009; 12:E35-E70.
3. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJE, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician 2009: 12:699-802.
4. Centers for Disease Control and Prevention National Center for Health Statistics. Health, United States, 2006 with chartbook on trends in the health of Americans. Hyattsville, MD, 2006.
5. Clark J. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symp Management 2002; 23:131-137.
6. Burgess F. Highlights from pain, opioids, and addiction: An urgent problem for doctors and patients. Medscape Neurology and Neurosurgery 2007. www.medscape.com/viewarticle/555145_print. Accessed April 13, 2009.
7. Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11: S63-S88.
8. Trescot A, Helm S, Hansen H, Benyamin R, Glaser S, Adlaka R, Patel S, Manchikanti L. Opioids in the management of chronic non-cancer pain: An update of American Society of Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11: S5-S62.
9. Ramsin B, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician 2008; 11:S105-S120.
10. Smith HS. Peripherally-acting opioids. Pain Physician 2008; 11:S121-S132.
11. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician 2008; 11:S133-S153.
12. Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: Tools, techniques, and utility. Pain Physician 2008; 11:S155-S180.
13. Trescot AM, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 2008; 11:S181-S200.
14. Manchikanti L, Manchukonda R, Pampati V, Damron K, Brandon D, Cash K, McManus C. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician 2006; 9:123-129.
15. Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, McManus CD. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Pain Physician 2006; 9:215-226.
16. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manage 2007; 3:89-100.
17. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash KA. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006; 9:57-60.
18. Manchikanti L, Fellows B, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: An evaluation of patterns and trends. J Ky Med Assoc 2005; 103:55-62.
19. Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC, Fellows B. Prevalence of prescription drug abuse and dependency in patients with chronic pain in western Kentucky. J KY Med Assoc 2003; 101:511-517.
20. Manchikanti L, Damron KS, McManus CD, Barnhill RC. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician 2004; 7:431-437.
21. Manchikanti KN, Manchikanti L, Damron KS, Pampati V, Fellows B. Increasing deaths from opioid analgesics in the United States: An evaluation in an interventional pain management practice. J Opioid Manage 2008; 4:271-283.
22. Practitioner's Manual: An informational outline of the controlled substance act of 1970. Drug Enforcement Administration 2006.
23. NSDUH Report: Trends in Nonmedical Use of Prescription Pain Relievers: 2002 to 2007. Substance Abuse and Mental Health Services Administration Office of Applied Studies. February 5, 2009.
24. Treatment Episode Data Set (TEDS): 1997-2007. National Admission to Substance Abuse Treatment Services. Substance Abuse and Mental Health Services Administration Office of Applied Studies 2009(DASIS Series S-47). 25.2007
25. National Survey on Drug Use and Health. Rockville, MD: U.S. Substance Abuse and Mental Health Services Administration; 2008.
26. Substance Abuse and Mental Health Services Office of Applied Studies. States in Brief: Indiana 2008. www.samhsa.gov/statesinbrief/2009/INDIANA_508.pdf. Accessed November 9, 2009.
27. Substance Abuse and Mental Health Services Office of Applied Studies. States in Brief: West Virginia 2008. www.samhsa.gov/statesinbrief/2009/WEST_VIRGINIA_508.pdf. Accessed November 9, 2009.
28. Substance Abuse and Mental Health Services Office of Applied Studies. States in Brief: Ohio. 2008. www.samhsa.gov/statesinbrief/2009/OHIO_508.pdf. Accessed November 9, 2009.
29. Kentucky Office of Drug Control Policy. Prescription drug abuse facts. 2009. http://odcp.ky.gov/NR/rdonlyres/01D7C27D-4E92-4939-9D6F-843E5D8A26E4/0/MicrosoftWordPrescriptionDrugAbuseFacts.pdf. Accessed July 29, 2009.
30. Kasier Family Foundation. State health facts. 2009. http://statehealthfacts.org. Accessed August 28, 2009.
31. Kentucky Justice & Public Safety Cabinet. Governor Ernie Fletcher holds ceremonial bill signing for anti-meth & internet pharmacy legislation. 2005. http://justice.ky.gov/pressreleases/methsigning.htm. Accessed August 29, 2009.
32. Kentucky Revised Statute. 315.0351 Out-of-state pharmacy Permit Requests for information Records Tollfree telephone service Pharmacist on duty Requirements for out-of-state pharmacy doing business on the Internet. 2007. www.lrc.ky.gov/krs/315-00/0351.pdf. Accessed July 29, 2009.
33. Kentucky Revised Statute. 533.010. Criteria for utilizing chapter Alternative sentences monitoring by private agency work release 2009. www.lrc.ky.gov/krs/533-00/010.pdf.
34. Kentucky Revised Statute. 533.250 Pretrial diversion program in each judicial circuit Elements Fee. 2009. www.lrc.ky.gov/krs/533-00/250.pdf. Accessed July 29, 2009.
35. Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): A public law for balancing treatment of pain and drug abuse and diversion. Pain Physician 2005; 8:335-347.
36. Wang J, Christo PJ. The influence of prescription monitoring programs on chronic pain management. Pain Physician 2009; 12:507-515.
37. Goldfarb B. Primary care physicians often miss signs of drug abuse in pain patients. Pain Med News 2005; 3(6). www.painmedicinenews.com/index.asp?section_id=82&show=dept&issue_id=120&article_id=4287. Accessed March 14, 2010.
38. Katz N, Sherburne S, Beach M, Rose R, Vielguth J, Bradley J, Fanciullo G. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003; 97:1097-1102.
39. Warner M, Chen L, Makuc D. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief 2009(22). www.cdc.gov/nchs/data/databriefs/db22.htm
40. Centers for Medicare and Medicaid Services. Qualitative drug screening L28145. 2009. www.ngsmedicare.com/NGSMedicare/lcd/DL28145_f_lcd.htm.
41. Reynolds L. Historical aspects of drugsof-abuse testing in the United States. In: Wong R, Tse H, (eds). Forensic Science and Medicine: Drugs of Abuse: Body Fluid Testing. Humana Press, Totowa, NJ, 2006.
42. Swotinsky R, Smith D. The Medical Review Officer's Manual. 3rd ed. OEM Press, Beverly Farms, MA, 2006.
43. TRICARE Management Activity. Military drug program historical timeline. 2008. www.tricare.mil/tma/DDRP/documents/72208/DoD%20Drug%20Policy%20History.pdf. Accessed August 10, 2009.
44. MacDonald D, DuPont R, Ferguson J. The role of the medical review officer. In: Graham A, Schultz T, Smith MM, Ries R, Wilford B, (eds). Principles of Addiction Medicine. American Society of Addiction Medicine, Chevy Chase, MD, 2003: 944.
45. Reagan R. Drug-free federal workplace: 51 FR 32889, 3 CFR, 1986 Comp., p. 224.
46. Clark H. The role of physicians as medical review officers in workplace drug testing programs: In pursuit of the last nanogram. West J Med 1990; 152:514-524.
47. Zwerling C, Ryan J, Orav EJ. The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA 1990; 264:2639-2643.
48. Zwerling C, Ryan J, Orav EJ. Costs and benefits of preemployment drug screening. JAMA 1992; 267:91-93.
49. Judge W. Workplace drug testing's mixed success. Behavioral healthcare. 2007 www.behavioral.net/ME2/dirmod.asp?sid=&nm=&type=Publishing&mod=Publications%3A%3AArticle&mid=64D490AC6A7D4FE1AEB453627F1A4A32&id=0C9F56F8A9A34FA5A0D99CA94EF0B6D5&tier=4. Accessed August 28, 2009.
50. Gerson B, Subramaniam S. Drug testing as part of the war on drugs. Clin Lab Med 1998; 18:781-803.
51. Peat M. Financial viability of screening for drugs of abuse. Clin Chem 1995; 41:805-808.
52. Moeller K, Lee K, Kissack J. Urine drug screening: Practical guide for clinicians. Mayo Clin Proc 2008; 83:66-76.
53. Lessenger J, Roper G. Drug courts: A primer for the family physician. J Am Board Fam Pract 2002; 15:298-303.
54. Laudet A. The impact of Alcoholics Anonymous on other substance abuse related Twelve Step programs. Recent Dev Alcohol 2008; 18:71-89.
55. Narcotics Anonymous. 2009. http://wapedia.mobi/en/Narcotics_Anonymous. Accessed August 29, 2009.
56. U.S. Food and Drug Administration. Conditions for the use of narcotic drugs. 21 CFR 291505. 2000. http://frwebgate.access.gpo.gov/cgi-bin/getcfr.cgi?TITLE=21&PART=291&SECTION=505&YEAR=2000&TYPE=TEXT. Accessed June 11, 2009.
57. U.S. Department of Health and Human Services. Emergency Department Trends from the Drug Abuse Warning Network, Preliminary Estimates January-June 2002. Rockville, MD. SAMHSA Office of Applied Studies, 2002.
58. Wasserman D, Korcha R, Havassy B, Hall S. Detection of illicit opioid and cocaine use in methadone maintenance treatment. Am J Drug Alcohol Abuse 1999; 25:561-571.
59. Chutuape M, Silverman K, Stitzer M. Effects of urine testing frequency on outcome in a methadone take-home contingency program. Drug and Alcohol Depend 2001; 62:69-76.
60. Ojaniemi K, Lintoen T, Impinen A, Lillsunde P, Ostamo A. Trends in driving under the influence of drugs: A register-based study of DUID suspects during 1977-2007. Accid Anal Prev 2009; 41:191-196.
61. Ehrman R, Robbins S, Cornish J. Results of a baseline urine test predict levels of cocaine use during treatment. Drug and Alcohol Depend 2001; 62:1-7.
62. Epstein D, Schmittner J, Umbricht A, Schroeder J, Moolchan E, Preston K. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug and Alcohol Depend 2009; 101:92-100.
63. Lukachko A. Pain education lacking in medical school curricula. Primary Care Quarterly 2009; 5(9).
64. Kuznar W. Understanding of opioids key to chronic pain treatment. Int Med World Rept 2007(June). www.hcplive.com/primary-care/publications/internal-medicine-world-report/2007/2007-06/2007-06_31. Accessed March 14, 2010.
65. Reisfield G, Salazar E, Bertholf R. Rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci 2007; 37:301-14.
66. Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming M. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006; 22:1859-1865.
67. Tellioglu T. The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions. Med Health R I 2008; 91:279-280.
68. Passik S, Schreider J, Kirsch K, Portenoy R. A chart review of the ordering and documentation or urine toxicology screens in a cancer center: Do they influence pain management? J Pain Symptom Manage 2000; 19:40-44.
69. Kuehn BM. Efforts aim to curb opioid deaths, injuries. JAMA 2009; 301:1213-5.
70. Ives T, Chelminski P, Hammett-Stabler C, Malone R, Perhac J, Potisek N, Shilliday B, DeWait D, Pignone M. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006; 6:46.
71. Cone E, Caplan Y, Black D, Robert T, Moser F. UDT of chronic pain patients: Licit and illicit drug patterns. J Anal Toxicol 2008; 32:530-543.
72. Jung B, Reidenberg M. Physicians being deceived. Pain Med 2007; 8:433-7.
73. Fishbain D, Cutler R, Rosomoff H, Rosomoff R. Validity of self-reported drug use in chronic pain patients. Clin J Pain 1999; 15:184-191.
74. Passik S, Kirsch K. Commentary on Jung and Reidenberg's Physicians Being Deceived: Aberrant drug-taking behaviors: What pain physicians can know (or should know). Pain Med 2007; 8:442-4.
75. Garcia L. 2008 8th ICPCD highlights review 3: Role of urine drug testing in monitoring pain and addiction therapy: Is it worth it? Faculty presenter Howard Heit. 2008. www.emergingsolutionsinpain.com/index.php?option=com_content&task=view&id=398&Itemid=105. Accessed August 10, 2009.
76. Beresford L, Dhingra LK. Tools for pain and opioid abuse risk assessment. Medscape 2009. http://cme.medscape.com/viewarticle/585622. Accessed May 8, 2009.
77. Fornari F, Siwicki D, Bauer G. Urine testing and monitoring in pain management. Practical Pain Management July 2006.
78. Heit HA, Gourlay D. Urine drug testing in pain medicine. J Pain Symp Management 2004; 27:260-7.
79. Kleber HD, Heit HA, Nicholson B. Opioid Risk Management: Dispelling the Myths and Integrating Clinical Strategies to Protect Your Practice. Purdue University, West Lafayette, IN, 2009.
80. Michna E, Jamison R, Pham L, Ross E, Janfaza D, Nedeljkovic S, Narang S, Palombi D, Wasan A. Urine toxicology screening among chronic pain patients on opioid therapy: Frequency and predictability of abnormal findings. Clin J Pain 2007; 23:173-9.
81. Katz N, Fanciullo G. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain 2002; 18:S76-S82.
82. Ziegler D. Opioids in headache treatment: Is there a role? Neurol Clin 1997; 15:199-207.
83. Tennant F. Brain atrophy with chronic pain. Practical Pain Management 2009; 9.
84. Estate of Henry James v Hillhaven Corp, 89 (North Carolina Sup. Ct. Div 1991).
85. Bergman v Chin, H205732 (Cal. Super. Ct. Alameda County 2001).
86. Tomlinson v Bayberry Care Center, C 02-00120 (Cal. Super. Ct. Contra Costa County 2002).
87. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy R. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003; 289:2370-8.
88. Barry DT, Beitel M, Cutter CJ, Garnet B, Joshi D, Schottenfeld RS, Rounsaville BJ. Allopathic, complementary, and alternative medical treatment utilization for pain among methadone-maintained patients. Am J Addict 2009; 18:379-385.
89. Office of Applied Studies. Results from the National Survey on Drug Use and Health: National findings (DHHS Publication No. SMA 08-4343, NSDUH Series H-34). 2008. www.drugabuse.gov/Infofacts/PainMed.html. Accessed August 28, 2009.
90. National survey of drug use and health. Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; 2007.
91. Jamison R, Kauffman J, Katz N. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000; 19:53-62.
92. New report cites surge in painkiller abuse admissions. Primary care quarterly 2009; 9. www.pcquarterly.com/index.asp?section_id=171&show=dept&issue_id=514&article_id=13082. Accessed March 14, 2010.
93. Bollinger L, Bush C, Califano J, Chenault K, Curtis J, Dimon J, Dolan P, FIsher M, Ganzi V, Kelmenson L-A, Keough D, Kessler D, Malloy E, Pacheco M, Plumeri J, Redstone S, Rosenwald E, Schulhof M, Sullivan L, Sweeney J, Wiener M. Under the counter: The diversion and abuse of controlled prescription drugs in the U.S. The National Center on Addiction and Substance Abuse at Columbia University; 2005.
94. The NSDUH Report: Trends in Nonmedical Use of Prescription Pain Relievers: 2002 to 2007. Rockville, MD: Substance Abuse and Mental Health Services Administration OoAS; 2009.
95. Paulozzi L. Trends in unintentional drug poisoning deaths. Committee on Energy & Commerce, Subcommittee on Oversight & Investigations, United States House of Representatives: CDC Congressional Testimony; October 24, 2007.
96. Graham N, Gold M, Goldberger B. Prescription opioids and overdose deaths. JAMA 2009; 301:1766-1768.
97. Shields L, Hunsaker J, Corey T, Ward M, Stewart D. Methadone toxicity fatalities: A review of medical examiner cased in a large metropolitan area. J Forensic Sci 2007; 52:1389-1395.
98. Kentucky Office of Drug Control Policy. Results of the 2006 Kentucky Incentives for Prevention Survey. The Drug factor 2007; 1:1.
99. Kentucky Justice & Public Safety Cabinet Office of Drug Control Policy. Opiate addiction increases among youth. The drug factor 2008; 1:1.
100. U.S. Department of Justice Drug Enforcement Administration. Kentucky State Fact Sheet. 2009. www.usdoj.gov/dea/pubs/state_factsheets/kentucky.html. Accessed June 12, 2009.
101. U.S. Department of Health and Human Services. Summary of findings from the 2000 national household survey on drug abuse. In: Substance Abuse and Mental Health Services Administration 2000.
102. McCarthy W, Zhou Y, Hser Y, Collins C. To smoke or not to smoke: Impact on disability, quality of life, and illicit drug use in baseline polydrug users. J Addict Dis 2002; 21:35-54.
103. Richter K, Ahluwalia H, Mosier M, Nazir N, Ahluwalia J. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 2002; 97:861-869.
104. Horgan C. Substance abuse: The nation's number one health problem: Key indicators for policy: Update. Robert Wood Johnson Foundation, Princeton, NJ, 2001.
105. Elkholm O, Gronbaek M, Peuckmann V, Sjogren P. Alcohol and smoking behavior in chronic pain patients: The role of opioids. Eur J Pain 2009; 13:606-612.
106. John U, Hanke M, Meyer C, Volzke H, Baumeister S, Alte D. Tobacco smoking in relation to pain in a national general population survey. Prev Med 2006; 43:477-481.
107. Akmal M, Kesani A, Anand B, A S, Wiseman M, Goodship A. Effect of nicotine on spinal disc cells: A cellular mechanism for disc degeneration. Spine. 2004; 29:568-575.
108. Davidson L. Cigarette smoking and its impact on spinal fusions. 2009. Available from: www.spineuniverse.com/wellness/cigarette-smoking-its-impact-spinal-fusions. Accessed August 29, 2009.
109. Fishbain D. Report on the prevalence of drug/alcohol abuse and dependence in chronic pain patients (CCPs). Sutst Use Misuse 1996; 31:945-946.
110. Hoffman N, Olofsson O, Salen B, Wickstrom L. Prevalence of abuse and dependency in chronic pain patients. Int J Addict 1995; 30:919-927.
111. Reid M, Engles-Horton L, Weber M, Kerns R, Rogers E, O'Connor P. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002; 17:173-179.
112. Patterson T, Jeste D. The potential impact of the baby-boom generation on substance abuse among elderly person. Psychiatric Services 1999; 50:1184-1188.
113. Chabel C, Erjavec M, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain 1997; 13:150-1555.
114. Manchikanti L, Manchikanti KN, Pampati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician 2009; 12:259-267.
115. Manchikanti L, Pampati V, Damron KS, Fellows B, Barnhill R, Beyer C. Prevalence of opioid abuse in interventional pain medicine practice settings: A randomized clinical evaluation. Pain Physician 2001; 4:358-365.
116. Saper J, 3rd LA, Hamel R, Lutz T, Branca B, Sims D, Kroll M. Daily scheduled opioids for intractable head pain: Longterm observations of a treatment program. Neurology 2004; 62:1687-1694.
117. Pembrook L. Two screening tests scrutinize urine, identify noncompliant patients. Clin Pain Med August 2005. www.painmedicinenews.com/index.asp?section_id=82&show=dept&issue_id=118&article_id=4265. Accessed June 6, 2009.
118. Pembrook L. High incidence of abnormal urine screens in patients with chronic pain. Pain Med News 2007; 5: http://www.painmedicinenews.com/index.asp?section_id=82&show=dept&issue_id=288&article_id=7912. Accessed March 14, 2010.
119. Workman E, Hubbard J, Felker B. Comorbid psychiatric disorders and predictors of pain management program success in patients with chronic pain. Prim Care Companion J Clin Psychiatry 2002; 4:137-40.
120. Darke S, Wodak A, Hall W, Heather N, Ward J. Prevalence and predictors of psychopathology among opioid users. Br J Addict 1992; 87:771-776.
121. Reiger D, Locke B, Burke J, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990; 264: 2511-2518.
122. Wasan A, Butler S, Budman S, Fermandez K, Jamison R. Psychiatric History and Psychological Adjustment as Risk Factors for Aberrant Drug-related Behavior Among Patients with Chronic Pain. Program and abstracts of the American Academy of Pain 23rd Annual Meeting; 2007. New Orleans, LA, 2007.
123. Tunks E, Crook J, Weir R. Epidemiology of chronic pain with psychological comorbidity: prevalence, risk course, and prognosis. La revue canadienne de psychiatrie 2008; 53:224-234.
124. Hitchcock LS, Ferrell BR, McCaffery M. The experience of chronic nonmalignant pain. J Pain Symptom Manage 1994; 9:312-318.
125. Snowdon J, Baume P. A study of suicides of older people in Sydney. Int J Geriatr Psychiatry 2002; 17:261-269.
126. Arharonovich E, Liu X, Nunes E, Hasin D. Suicide attempts in substance abusers: Effects of major depression in relation to substance use disorders. Am J Psychiatry 2002;159:1600-1602.
127. Goldsmith S, Pellmar T, Kleinman A, Bunney W. Reducing suicide: A national imperative. The National Academies Press, Washington, D.C., 2002.
128. Weiss R, Stephens P. Substance abuse and suicide. In: Jacobs D, (ed). Suicide and Clinical Practice. American Psychiatric Press, Washington, D.C., 1992.
129. Kentucky Suicide, Death & Self-Injury Statistics. Frankfort, Kentucky: Cabinet for Health & Family Services, Office for Health Policy, Department for Public Health and Department for Mental Health & Mental Retardation Services; 2005.
130. Shea SC. The practical art of suicide assessment: A Guide for Mental Health Professionals and Substance Abuse Counselors. John Wiley & Sons, Inc, Hoboken, NJ, 2002.
131. Buck J, Miller K. Mental health and substance abuse services in Medicaid, 1995. DHHS Pub. No. (SMA) 02-3713. Rockville, MD: Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, 2002.
132. Synthes. Snythes spine technical guide SynFix-LR system: Instruments and implants for standalone anterior lumbar interbody fusion. www3.hi.is/pub/hjjr/skrar/036285.pdf
133. Medtronic. Spinal cord stimulation: Iindications, safety & warnings. 2009. http://professional.medtronic.com/interventions/spinal-cord-stimulation/overview/index.htm. Accessed June 11, 2009.
134. Medtronic. Intrathecal drug delivery: Patient selection. 2009. http://professional.medtronic.com/interventions/intrathecal-drug-delivery/patient-selection/index.htm. Accessed June 11, 2009.
135. Manchikanti L, Boswell MV, Manchukonda R, Cash KA, Giordano. Influence of prior opioid exposure on diagnostic facet joint nerve blocks. J Opioid Manage 2008; 4:351-360.
136. Manchikanti L, Cash KA, Pampati V, Fellows B. Influence of psychological variables on the diagnosis of facet joint involvement in chronic spinal pain. Pain Physician 2008; 11:145-160.
137. Manchikanti L, Boswell MV, Singh V, Derby R, Fellows B, Falco FJE, Datta S, Smith HS, Hirsch JA. Comprehensive review of neurophysiologic basis and diagnostic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E71-E120.
138. Carragee EJ, Alamin TF, Carragee JM. Low-pressure positive discography in subjects asymptomatic of significant low back pain illness. Spine 2006; 31:505-509.
139. Carragee EJ, Tanner CM, Yang B, Brito JL, Truong T. False-positive findings on lumbar discography. Reliability of subjective concordance assessment during provocative disc injection. Spine 1999; 24:2542-2547.
140. Carragee EJ, Tanner CM, Khurana S, Hayward C, Welsh J, Date E, Truong T, Rossi M, Hagle C. The rates of falsepositive lumbar discography in select patients without low back symptoms. Spine 2000; 25:1373-1380; discussion 1381.
141. Carragee EJ, Alamin TF, Miller J, Grafe M. Provocative discography in volunteer subjects with mild persistent low back pain. Spine J 2002; 2:25-34.
142. Manchikanti L, Boswell MV, Datta S, Fellows B, Abdi S, Singh V, Benyamin RM, Falco FJE, Helm S, Hayek S, Smith HS. Comprehensive review of therapeutic interventions in managing chronic spinal pain. Pain Physician 2009: 12:E123-E198.
143. Atluri S, Datta S, Falco FJE, Lee M. Systematic review of diagnostic utility and therapeutic effectiveness of thoracic facet joint interventions. Pain Physician 2008; 11:611-629.
144. Falco FJE, Erhart S, Wargo BW, Bryce DA, Atluri S, Datta S, Hayek SM. Systematic review of diagnostic utility and therapeutic effectiveness of cervical facet joint interventions. Pain Physician 2009; 12:323-344.
145. Datta S, Lee M, Falco FJE, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions. Pain Physician 2009; 12:437-460.
146. Singh V, Manchikanti L, Shah RV, Dunbar EE, Glaser SE. Systematic review of thoracic discography as a diagnostic test for chronic spinal pain. Pain Physician 2008; 11:631-642.
147. Wolfer L, Derby R, Lee JE, Lee SH. Systematic review of lumbar provocation discography in asymptomatic subjects with a meta-analysis of false-positive rates. Pain Physician 2008; 11:513-538.
148. Manchikanti L, Dunbar EE, Wargo BW, Shah RV, Derby R, Cohen SP. Systematic review of cervical discography as a diagnostic test for chronic spinal pain. Pain Physician 2009; 12:305-321.
149. Manchikanti L, Glaser S, Wolfer L, Derby R, Cohen SP. Systematic review of lumbar discography as a diagnostic test for chronic low back pain. Pain Physician 2009; 12:541-559.
150. Conn A, Buenaventura R, Datta S, Abdi S, Diwan S. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009; 12:109-135.
151. Parr AT, Diwan S, Abdi S. Lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain: A systematic review. Pain Physician 2009; 12:163-188.
152. Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician 2009; 12:137-157.
153. Buenaventura RM, Datta S, Abdi S, Smith HS. Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Physician 2009; 12:233-251.
154. Helm S, Hayek S, Benyamin RM, Manchikanti L. Systematic review of the effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician 2009; 12:207-232.
155. Smith HS, Chopra P, Patel VB, Frey ME, Rastogi R. Systematic review on the role of sedation in diagnostic spinal interventional techniques. Pain Physician 2009; 12:195-206.
156. Hirsch JA, Singh V, Falco FJE, Benyamin RM, Manchikanti L. Automated percutaneous lumbar discectomy for the contained herniated lumbar disc: A systematic assessment of evidence. Pain Physician 2009; 12:601-620.
157. Singh V, Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Percutaneous lumbar laser disc decompression: A systematic review of current evidence. Pain Physician 2009; 12:573-588.
158. Singh V, Benyamin RM, Datta S, Falco FJE, Helm S, Manchikanti L. Systematic review of percutaneous lumbar mechanical disc decompression utilizing Dekompressor. Pain Physician 2009; 12:589-599.
159. Manchikanti L, Derby R, Benyamin RM, Helm S, Hirsch JA. A systematic review of mechanical lumbar disc decompression with nucleoplasty. Pain Physician 2009; 12:561-572.
160. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Effectiveness of thoracic medial branch blocks in managing chronic pain: A preliminary report of a randomized, double-blind controlled trial; Clinical trial NCT00355706. Pain Physician 2008; 11:491-504.
161. Manchikanti L, Singh V, Falco FJ, Cash KA, Fellows B. Cervical medial branch blocks for chronic cervical facet joint pain: A randomized double-blind, controlled trial with one-year follow-up. Spine (Phila Pa 1976) 2008; 33:1813-1820.
162. Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V. Lumbar facet joint nerve blocks in managing chronic facet joint pain: One-year follow-up of a randomized, double-blind controlled trial: Clinical Trial NCT00355914. Pain Physician 2008; 11:121-132.
163. Manchikanti L, Cash KA, McManus CD, Pampati V, Smith HS. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 1. Discogenic pain without disc herniation or radiculitis. Pain Physician 2008; 11:785-800.
164. Manchikanti L, Singh V, Cash KA, Pampati V, Damron KS, Boswell MV. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 2. Disc herniation and radiculitis. Pain Physician 2008; 11:801-815.
165. Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 3. Post surgery syndrome. Pain Physician 2008; 11:817-831.
166. Manchikanti L, Cash KA, McManus CD, Pampati V, Abdi S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 4. Spinal stenosis. Pain Physician 2008; 11:833-848.
167. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: A systematic review. Pain Physician 2009; 12:379-397.
168. Epter RS, Helm S, Hayek SM, Benyamin RM, Smith HS, Abdi S. Systematic review of percutaneous adhesiolysis and management of chronic low back pain in post lumbar surgery syndrome. Pain Physician 2009; 12:361-378.
169. Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
170. Rupert MP, Lee M, Manchikanti L, Datta S, Cohen SP. Evaluation of sacroiliac joint interventions: A systematic appraisal of the literature. Pain Physician 2009; 12:399-418.
171. Hayek SM, Helm S, Benyamin RM, Singh V, Bryce DA, Smith HS. Effectiveness of spinal endoscopic adhesiolysis in post lumbar surgery syndrome: A systematic review. Pain Physician 2009; 12:419-435.
172. Manchikanti L, Singh V, Helm S, Schultz DM, Datta S, Hirsch J. An introduction to an evidence-based approach to interventional techniques in the management of chronic spinal pain. Pain Physician 2009; 12:E1-E33.
173. Spears V. Congress has national drugmonitoring system on hold. Lexington Herald-Leader April 12, 2009.
174. Gilbert J. Letter to the editors: Ten Cs of chronic non-cancer pain. Am J Pain Manage 2005; 15:45-7.
175. Federation of State Medical Boards. 2009. www.fsmb.org/. Accessed June 12, 2009.
176. Meadows M. Managing chronic pain. FDA Consumer magazine 2004. June 2004. www.fda.gov/FDAC/features/2004/204_pain.html. Accessed May 21, 2009.
177. Batki S, Kauffman J, Marion I, Parrino M, Woody G. TIP 43: medication-assisted treatment for opioid addiction in opioid treatment programs. SAMHSA/CSAT treatment improvement protocols. Rockville, MD: U.S. Department of Health and Human Services; 2004.
178. U.S. Department of Health and Human Services. Certification of opioid treatment programs: Federal opioid treatment standards. 42 CFR Part 8 12 (f) (6) 2001.
179. APS opioid guidelines nearing publication. Pain Med News 2008; 6.
180. Wooden J. Prescription drug abuse: What price pain relief? Pain Med News 2009; 8
181. McMillin G, Urry F. Drug Testing Guide for Chronic Pain Management Services. University of Utah, Salt Lake City, UT, 2007.
182. Louisiana Administrative Code, title 48, chapter 78, section 7831.
183. Campbell A. American Academy of Pain Management Pain Program Accreditation: Description and value. www.sbncmd.com/Pain%20Management%20Program%20Accreditation.pdf. Accessed June 25, 2009.
184. Gourlay D, Heit H, Caplan Y. Urine Drug Testing in Clinical practice: Dispelling the Myths and Designing Strategies. 3rd ed. PharmaCom Group, Stamford, CT, 2006.
185. Manchikanti L, Singh V, Pampati V, Boswell MF, Benyamin RM, Hirsch JA. Description of documentation in the management of chronic spinal pain. Pain Physician 2009: 12:E199-E224.
186. Manchikanti L, Manchukonda R, Pampati V, Damron KS. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician 2005; 8:257-261.
187. Berg K, Arnsten J, Sacajiu G, Karasz A. Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med 2009; 24:482-8.
188. Cheattle M, Gallagher R. Chronic pain and comorbid mood and substance use disorders: A biopsychosocial treatment approach. Current Psychiatry Reports 2006; 8:371-6.
189. Hojsted J, Sjogren P. Addiction to opioids in chronic pain patients: A literature review. European Journal of Pain 2007; 11:490-518.
190. Mitchell A, Dewey C. Chronic pain in patients with substance abuse disorder: General guidelines and an approach to treatment. Postgrad Med 2008; 120:75-79.
191. Heit H. Guidelines for urine drug monitoring for the pain patient in a clinical practice. Tufts Health Care Institute program on opioid risk management, 2008.
192. www.thci.org/Opioid/jun08docs/Heit%20UDM-%20Tufts%20-June%2026-27%202008%20%20Boston%2030%20min.pdf. Accessed June 24, 2009.
193. Gilbert J. Detecting noncompliance: treating pain without fear. [Letter]. Med Econ 2009; 86.
194. Gilbert JW, Wheeler GR, Lingreen RA, Martonffy D, Hatchett J, Gaines R, Stidham S, Sutton T, Westerfield G, McConnell M, Noble S, Carter K. The ten Cs of chronic non-cancer pain: Universal precautions for the chronic noncancer pain patient. Am J Pain Manage 2005; 15:22-32.
195. Manchikanti L, Damron KS, Pampati V, MCManus CD, Weaver SE. Prospective evaluation of patients with increasing opiate needs: Prescription opiate abuse and illicit drug use. Pain Physician 2004; 7:339-344.
196. Gilbert JW, Wheeler GR, Lingreen RA, Scheiner SJ, Upadhyay SP, GyartengDakwa K. Compliance in chronic noncancer pain patients on long-acting opiates, short-acting opiates, or non-opiates. Am J Pain Manage 2006; 16:121-7.
197. U.S. Department of Transportation. Procedures for transportation workplace drug and alcohol testing programs. 49 CFR Part 40. www.dot.gov/ost/dapc/NEW_DOCS/part40.html. Accessed June 11, 2009.
198. Marcus D. Managing chronic pain in the primary care setting. 2002. www.aafp.org/afp/20020701/editorials.html.
199. Kozma A. Urine drug screening in everyday practice. Practical Pain Management 2007; (April):18-20.
200. Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McManus CD, Brandon DE. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: A prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/ MS/MS). Pain Physician 2010; 13:E1-E22.
201. Manchikanti L, Boswell MV, Giordano J. Evidence-based interventional pain management: Principles, problems, potential and applications. Pain Physician 2007; 10:329-356.
202. Boswell MV, Trescot AM, Datta S, Schultz DM, Hansen HC, Abdi S, Sehgal N, Shah RV, Singh V, Benyamin RM, Patel VB, Buenaventura RM, Colson JD, Cordner HJ, Epter RS, Jasper JF, Dunbar EE, Atluri SL, Bowman RC, Deer TR, Swicegood JR, Staats PS, Smith HS, Burton AW, Kloth DS, Giordano J, Manchikanti L. Interventional techniques: Evidencebased practice guidelines in the management of chronic spinal pain. Pain Physician 2007; 10:7-111.
203. Manchikanti L, Giordano J. Physician payment 2008 for interventionalists: Current state of health care policy. Pain Physician 2007; 10:607-626.
204. Manchikanti L, Hirsch JA. Obama health care for all Americans: Practical implications. Pain Physician 2009; 12:289-304.
205. Manchikanti L. Health care reform in the United States: Radical surgery needed now more than ever. Pain Physician 2008; 11:13-42.
206. Manchikanti L, McMahon EB. Physician refer thyself: Is Stark II, Phase III the final voyage? Health Policy Update. Pain Physician 2007; 10:725-741.
207. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-E54.
208. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management